Abbott Medical Devices Trading (Shanghai) Co., Ltd.

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

POWER (Pulse Width Optimized Waveform Evaluation Trial)

Phase 4

Completed

Conditions: Sudden Cardiac Death

Interventions: Device: Implantable Cardioverter Defibrillator (ICD), Cardiac Resynchronization Therapy (CRT-D)

First Posted Date: 2006-04-05

Last Posted Date: 2019-02-20

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 217

Registration Number: NCT00311181

Locations: 🇺🇸
Baptist Medical Center Montclair, Birmingham, Alabama, United States
🇺🇸
Pacific Heart Institute, Santa Monica, California, United States

Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic Preference (VIP)

Not Applicable

Completed

Conditions: Bradycardia

Interventions: Device: Intervention/treatment

First Posted Date: 2006-04-05

Last Posted Date: 2021-08-12

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 135

Registration Number: NCT00311168

Locations: 🇺🇸
Abbott, Sylmar, California, United States

SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System

Phase 3

Completed

Conditions: Coronary Artery Disease

Interventions: Device: XIENCE V® Everolimus Eluting Coronary Stent
Device: TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent

First Posted Date: 2006-03-27

Last Posted Date: 2012-11-07

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 3687

Registration Number: NCT00307047

Locations: 🇺🇸
Wake Medical Center, Raleigh, North Carolina, United States
🇺🇸
Union Memorial Hospital, Baltimore, Maryland, United States
🇺🇸
Geisinger Medical Center, Danville, Pennsylvania, United States

and more 62 locations

CAPTURE 2 Post-Marketing Registry

Completed

Conditions: Carotid Artery Disease

Interventions: Device: RX ACCULINK, RX ACCUNET Embolic Protection System

First Posted Date: 2006-03-14

Last Posted Date: 2012-12-13

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 6426

Registration Number: NCT00302237

Locations: 🇺🇸
Abbott Vascular, Santa Clara, California, United States

ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation

Completed

Conditions: Coronary Disease
Coronary Artery Disease
Coronary Restenosis

Interventions: Device: Bioabsorbable Everolimus Eluting Coronary Stent

First Posted Date: 2006-03-08

Last Posted Date: 2011-09-13

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 30

Registration Number: NCT00300131

Locations: 🇳🇱
Erasmus University Thorax Center, Rotterdam, Netherlands
🇳🇿
Auckland City Hospital, Auckland, New Zealand
🇩🇰
Skejby Sygehus, Aarhus, Denmark

and more 1 locations

Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study)

Phase 4

Completed

Conditions: Carotid Artery Disease
Carotid Stenosis
Stroke
Atherosclerosis

First Posted Date: 2006-02-07

Last Posted Date: 2008-10-17

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 1500

Registration Number: NCT00287508

Frontier Registry II Bifurcation Stent System Registry

Phase 4

Withdrawn

Conditions: Coronary Artery Disease

Interventions: Device: Multi-Link Frontier Coronary Stent System

First Posted Date: 2006-02-03

Last Posted Date: 2015-05-13

Lead Sponsor: Abbott Medical Devices

Registration Number: NCT00286195

ESCAPE Migraine Trial

Phase 3

Terminated

Conditions: Migraine Disorders
Heart Septal Defects, Atrial

Interventions: Device: PFO Closure with Premere investigational device.
Drug: Medical management/current medications per standard of care by personal physician.

First Posted Date: 2005-12-20

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 168

Registration Number: NCT00267371

Locations: 🇺🇸
Alpine Clinical Research Center, Boulder, Colorado, United States
🇺🇸
Evanston Northwestern HealthCare, Evanston, Illinois, United States
🇺🇸
Upstate Clinical Research, LLC, Albany, New York, United States

and more 34 locations

Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial

Phase 4

Completed

Conditions: Atrial Fibrillation
Hypertension

Interventions: Device: AF Suppression Pacing Algorithm

First Posted Date: 2005-11-21

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 2580

Registration Number: NCT00256152

Locations: 🇨🇦
McMaster University, Hamilton, Ontario, Canada

REST Study: Left Ventricular Regression European Study

Phase 4

Completed

Conditions: Aortic Valve Stenosis

First Posted Date: 2005-11-21

Last Posted Date: 2019-02-04

Lead Sponsor: Abbott Medical Devices

Target Recruit Count: 150

Registration Number: NCT00256165

Locations: 🇩🇪
Städtlishes Klinikum Braunschweig, Braunschweig, Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy